Category Archives: Top Market News

Clarus Reaffirms Their Buy Rating on CRH Medical (CRH)

Shares of CRH Medical (CRH – Research Report) were revisited by a Wall Street analyst on March 14. Analyst Noel Atkinson from Clarus remains bullish on the stock. Atkinson wrote: “We believe a period of calm for reimbursement rates will

SunTrust Robinson Keeps Their Buy Rating on Yext Inc (YEXT)

In a report released today, Naved Khan from SunTrust Robinson maintained a Buy rating on Yext Inc (YEXT – Research Report), with a price target of $30. Khan said: “We view Yext’s new integration with Adobe products positively for the

Catabasis Pharmaceuticals (CATB) Gets a Buy Rating from Wedbush

In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Catabasis Pharmaceuticals (CATB – Research Report), with a price target of $20. The company’s shares opened today at $7.05. According to TipRanks.com, Moussatos has 0 stars

The President & CEO of Genocea Biosciences is Exercising Options

Today it was reported that the President & CEO of Genocea Biosciences (GNCA – Research Report), William D. Clark, exercised options to buy 15,000 GNCA shares at $0.54 a share, for a total transaction value of $8,100. Following this transaction

B.Riley FBR Remains a Buy on Medicines Co (MDCO)

B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on Medicines Co (MDCO – Research Report) today and set a price target of $38. The company’s shares opened today at $27.22. Mamtani commented: “We see positive lateral read-through to MDCO

Cantor Fitzgerald Thinks Taiwan Liposome Company Ltd’s Stock is Going to Recover

In a report released today, Matthew Lillis from Cantor Fitzgerald maintained a Buy rating on Taiwan Liposome Company Ltd (TLC – Research Report), with a price target of $11. The company’s shares opened today at $5.82, close to its 52-week